Ames, B.N., MaGaw, R. and Gold, L.S. (1987) Ranking possible carcinogenic hazards. Science, 236:271-280.
2.
Ayesh, R., Idle, J.R., Ritchie, J.C., Crothers, M.J. and Hetzel, M.R. (1984) Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature, 312:169-170.
3.
Harris, C.C. (1989) Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair . Carcinogenesis , 10(9):1563-1566.
4.
Hoel, D.G. (1990) Methodological issues of the HERP index. Risk Analysis (in press).
5.
Hoel, D.G., Haseman, J.K., Hogan, M.D., Huff, J.E. and McConnell, E.E. (1988) The impact of toxicity on carcinogenicity studies: Implications for risk assessment. Carcinogenesis, 9:2045-2052.
6.
Hoel, D.G. and Porter, C.J. (1990) Nonlinearity of dose-response functions for carcinogenicity. (In revision)
7.
Kawashima, K. , Shikama, H., Imoto , K., Izawa, M., Naruke, T., Okabayashiand Nishimura, S. (1988) Close correlation between restruction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs. Proc. Natl. Acad. Sci . 85:2353-2356.
8.
Lidereau, R. , Escot, C., Theillet , C., Champeme, M., Brunet, M., Gest, J. and Callahan, R. (1986) High frequency of rare alleles of the human c-Ha-ras-1 proto-oncogene in breast cancer patients. JNCI, 77(3):697-701.
9.
Portier, C. and Kaplan, N. (1989) The variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: Methylene Chloride . Fundamental and Applied Toxicology, 13:(in press).
10.
Ryan, J., Barker, P.E., Nesbitt, M.N. and Ruddle, F.H. (1987) KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. JNCI, 79(6):1351-1357.
11.
Storer, J.B. , Mitchell, T.J. and R.J . (1988) Extrapolation of the relative risk of radiogenic neoplasms across mouse strains and to man. Radiation Research, 114(2):331-353.